U.S. FDA approves RedHill's H. pylori infection treatment

U.S. FDA approves RedHill's H. pylori infection treatment
Reuters: Health
The U.S. Food and Drug Administration has approved RedHill Biopharma Ltd's drug to treat infections caused by bacteria known as Helicobacter pylori, the Israel-based company said on Monday.


No comments:

Post a Comment